VYXEOS: The first chemotherapy for adults newly diagnosed with t-AML or AML-MRC (non-PSONS), 12/13, Tacoma

Posted on 27. Oct, 2017 by in non-PSONS

VYXEOS: The first chemotherapy for adults newly diagnosed with t-AML or AML-MRC

Wednesday, December 13, 2017
6:00 PM Pacific

El Gaucho
2119 Pacific Avenue
Tacoma, WA 98402

Presented By:

BART SCOTT, MD
Assistant Member, Clinical Research Division,
Fred Hutch
Associate Professor of Medicine, Division of Oncology,
University of Washington
Director of Hematology and Hematologic Malignancies,
Seattle Cancer Care Alliance

RSVP
Tiffany Wintermute
Cell 206-890-0424
tiffany.wintermute@jazzpharma.com

Click here to download the flyer: Tacoma Dinner 12.13.17 El Gaucho Bart Scott MD

Comments are closed.